CClinicalTrials.gg
CompletedNCT04787458Updated Mar 8, 2021

Effect of Abdominal Binder After Laparoscopic Cholecystectomy on Enhanced Recovery

An interventional study of abdomen binder (Sejung Korea, Seoul, Republic of Korea) in Laparoscopy, sponsored by Kangbuk Samsung Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-08.

Sponsored by Kangbuk Samsung Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Aug 2020, registered Feb 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

There have been reports that abdominal binder use after laparoscopic or open surgery affects postoperative respiratory function, walking performance, and pain but no study has evaluated binder use solely for laparoscopic cholecystectomy surgery. Therefore, the investigators performed a randomized controlled trial to evaluate the effect of abdominal binders after laparoscopic cholecystectomy by comparing postoperative outcomes in two patient groups.

Read the detailed description

Abdominal binders help to prevent postoperative complications, however, their use is controversial because of a lack of evidence for their effectiveness and because they also confer disadvantages. The purpose of this randomized controlled trial was to compare the effects of abdominal binder after laparoscopic cholecystectomy on pain, degree of comfort, time until ambulation, walking ability, return of bowel function, and diet resumption.

02

Conditions studied

  • Laparoscopy
03

In context

Lead sponsor

Kangbuk Samsung Hospital is the lead sponsor of 59 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18-65 years old
  • American Society of Anesthesiologists Physical Status classification I and II

Exclusion criteria

Exclusion Criteria:

  • history of ventral hernia
  • walking disability
  • chronic obstructive respiratory disease
  • malignancy
  • chronic pain syndrome
  • open conversion
  • inability to complete the questionnaire
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
65 participants (actual)

Study arms

  • Experimental
    Experimental group

    In subjects allocated to the abdominal binder group, the abdomen binder with a standard height of 22 cm (Sejung Korea, Seoul, Republic of Korea) was applied before leaving the operating room. Subjects were carefully instructed to use the abdominal binder during at least the first 2 consecutive days and night, and to reposition the abdominal binder correctly when needed.

    Device: abdomen binder (Sejung Korea, Seoul, Republic of Korea)

  • No intervention
    Control group

    subjects allocated in the control group, subjects were not given any opportunity to ware an abdominal binder.

Interventions

  • Deviceabdomen binder (Sejung Korea, Seoul, Republic of Korea)

    abdomen binder with a standard height of 22 cm (Sejung Korea, Seoul, Republic of Korea)

06

What researchers measure

Primary outcomes

  1. degree of comfort

    Questionnaire response options ranged from very comfortable (5) to very Questionnaire response options ranged from very comfortable (5) to very uncomfortable (0).

    Time frame: Until dischage, an average of 2.5 days

  2. postoperative pain

    Subjects rated postoperative pain intensity using a visual analog scale (0-10, VAS) at 12 hours after surgery

    Time frame: 12 hours after surgery

  3. postoperative pain

    Subjects rated postoperative pain intensity using a visual analog scale (0-10, VAS) at 24 hours after surgery

    Time frame: 24 hours after surgery

  4. postoperative pain

    Subjects rated postoperative pain intensity using a visual analog scale (0-10, VAS) at 48 hours after surgery

    Time frame: 48 hours after surgery

Secondary outcomes

  1. Postoperative hospital stay

    Postoperative hospital stay days to discharge

    Time frame: Until dischage, an average of 2.3 days

07

Study locations

1 site
  • Kangbuk Samsung Hospital
    Seoul, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04787458
Lead sponsor
Kangbuk Samsung Hospital
Responsible party
Sung Ryol Lee (Hepato-biliary and pancreatic department of General Surgery, Assistant Professor, Kangbuk Samsung Hospital) — Principal investigator
First posted
Mar 8, 2021
Start date
Aug 9, 2020
Primary completion
Dec 20, 2020
Completion
Feb 10, 2021
Last update
Mar 8, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion